ZYDUSLIFE share price & delivery %

Filings & corporate actions

86 results filed

CSV

Next results · Q2 FY27

Expected 29 Oct 2026 – 12 Nov 2026

Estimate: filed 29–43 days after quarter end, last 5 times

Dividend

₹1.00 per share · last 24 Jul 2026

2026

11 AugresultsResults · Q1 FY27 · consolidated and standalone+1.2%NSE
24 JuldividendDividend · ₹1.00 per share-0.5%
29 MaybuybackBuy Back-0.7%
19 MayresultsResults · Q4 FY26 · consolidated and standalone+2.2%NSE
9 FebresultsResults · Q3 FY26 · consolidated and standalone-3.9%NSE

Reaction to results · all yearsrose on day 0 in 41 of 78 CSV

Quarter	Filed	Day 0	+5D	+20D	Rel vol
Q1 FY27	11 Aug 2026	+1.2%	-7.3%	-5.3%	3.4×
Q4 FY26	19 May 2026	+2.2%	+6.6%	+5.4%	10.1×
Q3 FY26	9 Feb 2026	-3.9%	-1.8%	-0.2%	3.5×
Q2 FY26	6 Nov 2025	+0.8%	+0.8%	-0.6%	0.8×
Q1 FY26	12 Aug 2025	+3.4%	+3.2%	+9.3%	2.3×
Q4 FY25	20 May 2025	+0.7%	+4.8%	+8.5%	1.6×
Q3 FY25	5 Feb 2025	+3.2%	-3.5%	-7.8%	5.9×
Q2 FY25	12 Nov 2024	+1.5%	-0.1%	+3.0%	1.7×
Q1 FY25	9 Aug 2024	-3.9%	-8.3%	-14.4%	1.6×
Q4 FY24	17 May 2024	+5.0%	+0.7%	+2.6%	0.0×
Q3 FY24	9 Feb 2024	+6.4%	+12.7%	+23.5%	5.6×
Q2 FY24	7 Nov 2023	+4.7%	+4.0%	+10.2%	4.5×
Q1 FY24	11 Aug 2023	-1.0%	-0.7%	-4.5%	3.0×
Q4 FY23	18 May 2023	-2.6%	0.0%	+8.5%	3.5×
Q3 FY23	3 Feb 2023	+0.4%	+9.4%	+9.3%	1.2×
Q2 FY23	11 Nov 2022	-1.3%	-7.5%	-5.5%	0.9×
Q1 FY23	10 Aug 2022	+1.1%	+9.2%	+3.7%	1.2×
Q4 FY22	20 May 2022	+1.6%	+5.8%	-6.3%	2.6×
Q3 FY22	3 Feb 2022	-1.6%	-3.2%	-16.5%	1.3×
Q2 FY22	29 Oct 2021	+2.3%	+0.6%	-5.4%	2.1×
Q1 FY22	11 Aug 2021	-2.2%	-5.8%	-3.2%	2.2×
Q4 FY21	27 May 2021	-0.2%	+1.0%	-1.6%	1.2×
Q3 FY21	5 Feb 2021	-0.4%	-1.7%	-6.1%	1.0×
Q2 FY21	2 Nov 2020	+6.6%	-0.3%	+12.7%	6.5×
Q1 FY21	5 Aug 2020	-1.9%	-4.6%	-5.4%	4.1×
Q4 FY20	19 Jun 2020	-1.0%	-0.5%	+3.2%	1.0×
Q3 FY20	5 Feb 2020	+0.5%	-1.0%	-2.0%	4.8×
Q2 FY20	13 Nov 2019	+4.2%	+13.2%	+17.5%	3.8×
Q1 FY20	9 Aug 2019	-4.6%	-7.0%	+5.0%	1.5×
Q4 FY19	29 May 2019	-2.6%	-8.0%	-8.4%	0.9×
Q3 FY19	19 Feb 2019	+0.4%	+2.5%	+6.7%	0.5×
Q2 FY19	21 Nov 2018	-1.3%	+1.9%	-4.7%	0.5×
Q1 FY19	23 Aug 2018	+1.8%	+2.9%	+0.7%	1.2×
Q4 FY18	25 Jun 2018	-2.3%	-6.2%	-9.7%	0.4×
Q3 FY18	12 Mar 2018	+0.3%	-1.0%	+0.2%	0.9×
Q2 FY18	21 Nov 2017	+0.7%	-1.0%	-6.3%	0.8×
Q1 FY18	24 Aug 2017	+1.5%	+2.4%	-2.5%	1.3×
Q4 FY17	30 May 2017	+3.5%	+7.4%	+15.8%	1.5×
Q3 FY17	6 Feb 2017	+0.8%	+2.2%	+19.5%	0.9×
Q2 FY17	7 Nov 2016	-1.6%	-8.1%	+1.1%	0.9×
Q1 FY17	26 Sept 2016	-0.2%	-1.1%	-1.7%	0.6×
Q4 FY16	23 May 2016	+0.9%	+3.9%	-1.9%	0.7×
Q3 FY16	5 Feb 2016	+0.2%	-3.6%	+2.8%	0.7×
Q2 FY16	23 Oct 2015	+2.7%	-3.4%	-1.7%	5.4×
Q1 FY16	12 Aug 2015	-3.3%	-3.8%	-11.3%	1.3×
Q4 FY15	21 May 2015	-0.2%	+6.3%	+1.6%	1.9×
Q3 FY15	19 Feb 2015	-1.7%	-6.0%	-1.3%	0.2×
Q2 FY15	13 Nov 2014	-0.3%	-1.7%	+3.2%	1.7×
Q1 FY15	7 Aug 2014	+0.4%	+1.8%	+18.0%	0.4×
Q4 FY14	17 Jun 2014	+0.6%	+2.9%	+11.3%	0.7×
Q3 FY14	7 Feb 2014	+5.7%	+10.8%	+16.4%	12.0×
Q2 FY14	6 Nov 2013	+2.7%	+4.6%	+4.8%	3.1×
Q1 FY14	17 Aug 2013	-2.7%	-1.6%	+0.4%	2.5×
Q4 FY13	10 Jun 2013	-1.0%	+1.7%	+3.7%	1.6×
Q3 FY13	8 Feb 2013	-2.8%	-7.6%	-8.5%	5.5×
Q2 FY13	7 Nov 2012	-3.1%	-6.7%	-4.4%	7.1×
Q1 FY13	7 Aug 2012	-1.9%	-3.8%	-1.9%	0.8×
Q4 FY12	10 May 2012	+0.9%	+3.9%	-3.3%	2.0×
Q3 FY12	7 Feb 2012	-2.1%	+7.5%	+3.4%	2.7×
Q2 FY12	10 Nov 2011	-5.0%	-5.9%	-8.0%	1.5×
Q1 FY12	19 Jul 2011	-0.6%	-6.7%	-12.7%	1.8×
Q4 FY11	6 May 2011	+2.7%	+5.9%	+5.9%	3.1×
Q3 FY11	18 Jan 2011	-1.3%	+8.6%	+1.6%	3.6×
Q2 FY11	19 Oct 2010	-1.2%	+4.0%	+15.2%	0.9×
Q1 FY11	27 Jul 2010	+0.7%	-1.6%	-2.6%	2.6×
Q4 FY10	29 Apr 2010	-0.3%	+2.4%	+6.9%	1.9×
Q3 FY10	25 Jan 2010	+7.1%	+7.7%	+14.0%	11.6×
Q2 FY10	27 Oct 2009	+1.2%	+0.6%	+9.2%	1.6×
Q1 FY10	27 Jul 2009	+3.1%	+19.0%	+15.9%	1.8×
Q4 FY09	28 Apr 2009	-1.3%	+7.9%	+6.4%	1.1×
Q3 FY09	27 Jan 2009	+2.0%	+8.7%	+9.1%	0.8×
Q2 FY09	22 Oct 2008	-1.1%	-10.3%	-12.5%	0.1×
Q1 FY09	29 Jul 2008	+2.3%	+11.6%	+6.1%	1.2×
Q4 FY08	29 Apr 2008	+6.1%	+13.0%	+9.2%	3.7×
Q3 FY08	31 Jan 2008	-3.8%	-3.1%	-1.6%	0.3×
Q2 FY08	26 Oct 2007	-1.1%	+2.0%	-5.2%	1.8×
Q1 FY08	31 Jul 2007	-0.7%	+2.2%	-14.3%	1.3×
Q4 FY07	26 Apr 2007	+0.7%	+0.8%	+2.5%	1.5×
Average		+0.3%	+1.1%	+1.6%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV

Revenue YoY+22.0%

Profit YoY-34.9%

Interest cost YoY+133.6%

Revenue QoQ+5.7%

Profit QoQ-26.2%

CAGR	2Y	3Y	4Y	5Y	6Y	7Y
Revenue	+17.8%	+15.3%	+16.8%	+13.0%	+12.1%	+11.0%
Profit	+3.1%	+20.1%	+0.2%	+14.4%	+22.4%	+14.7%

Key data

CSV

Open1,145.00

Day range1,145.00 – 1,164.80

52-week range835.50 – 1,232.10

From 52w high-5.9%

RSI (14)51.1

ATR (14)30.60

Volume15.75L

Avg volume (20D)16.60L

Rel volume0.95×

Volatility (1Y)23.3%

Turnover₹182.7Cr

SMA 50 / 2001,142.71 / 1,013.36

Delivery percentage

Latest · 6 Oct 202653.4%

20-day avg52.0%

1-year avg50.8%

Percentile (own history)78th

Range7.5–100.0%

Sessions1,731

Over the last 20 sessions ZYDUSLIFE settled 52.0% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 50.8%. The latest session ranks higher than 78% of the 1,731 sessions on record for it.

What delivery percentage measures Scan the whole market on delivery

IndustryPharmaceuticals

PeersDIVISLAB LAURUSLABS SUNPHARMA WOCKPHARMA DRREDDY MOREPENLAB

Performance returns

CSV

	1D	1W	1M	3M	6M	1Y
Price	+1.80%	-4.57%	+1.44%	+0.56%	+34.16%	+18.92%

Valuation

CSV

Market cap₹1.16L Cr

P/E (TTM)25.2

EPS (TTM)46.04

Shares outstanding99.80Cr

Listed18 Apr 2000

Ownership

Promoter—

Promoter Δ QoQ—

Public—

FII—

DII—

Pledged—

Quarterly results · consolidated

CSV

	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue (₹ Cr)	6,123.2	6,864.5	7,587.0	8,017.0
YoY chg	+16.9%	+30.3%	+16.2%	+22.0%
Net profit (₹ Cr)	1,238.6	1,022.9	1,341.0	990.2
YoY chg	+34.6%	-0.3%	+7.8%	-34.9%
Net margin	20.2%	14.9%	17.7%	12.4%
EPS	12.51	10.36	12.65	9.35

Financials · quarterly statement

CSV

₹ crore, as filed

	Q2 FY24	Q3 FY24	Q4 FY24^A	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue from operations	4,368.8	4,505.2	5,533.8	6,207.5	5,237.0	5,269.1	6,527.9	6,573.7	6,123.2	6,864.5	7,587.0	8,017.0
Other income	54.0	37.7	156.4	63.2	68.2	57.5	80.6	154.9	109.0	111.4	134.2	106.1
Total income	4,422.8	4,542.9	5,690.2	6,270.7	5,305.2	5,326.6	6,608.5	6,728.6	6,232.2	6,975.9	7,721.2	8,123.1
Total expenses	3,415.6	3,617.4	4,143.2	4,371.0	4,034.3	4,142.5	4,716.9	4,808.0	4,510.6	5,537.6	5,664.0	6,798.3
└ Finance costs	8.7	19.8	34.6	32.2	25.1	32.0	76.6	84.7	101.3	129.9	123.0	156.0
└ Depreciation	184.2	194.8	205.3	215.3	233.6	229.0	237.9	238.1	301.9	359.6	508.4	554.7
Profit before tax	1,007.2	925.5	1,547.0	1,899.7	1,270.9	1,184.1	1,672.0	1,920.6	1,687.4	1,353.4	1,659.7	1,306.6
Tax expense	226.4	213.8	321.2	436.1	373.1	179.5	423.2	434.0	454.0	388.3	318.4	354.2
Net profit	803.2	789.9	1,246.1	1,482.5	920.2	1,026.2	1,243.7	1,521.0	1,238.6	1,022.9	1,341.0	990.2
EPS	7.91	7.80	11.69	14.11	9.06	10.17	11.64	14.58	12.51	10.36	12.65	9.35
Net margin	18.38%	17.53%	22.52%	23.88%	17.57%	19.48%	19.05%	23.14%	20.23%	14.90%	17.67%	12.35%
PBT margin	23.05%	20.54%	27.96%	30.60%	24.27%	22.47%	25.61%	29.22%	27.56%	19.72%	21.88%	16.30%
Tax rate	22.48%	23.10%	20.76%	22.96%	29.36%	15.16%	25.31%	22.60%	26.91%	28.69%	19.18%	27.11%

^A audited · ^R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 11 Aug 2026.

ZYDUSLIFE at a glance

ZYDUSLIFE closed at ₹1,159.5 on 6 Oct 2026, +1.80% on the day, +18.9% over one year, 5.9% below its 52-week high of ₹1,232.1.
Delivery was 53.4% of traded quantity on 6 Oct 2026, the 78th percentile of its own 1,731 sessions with a reading (20-session average 52.0%, 1-year average 50.8%).
Market capitalisation is ₹1.16 lakh crore at a trailing P/E of 25.2 (trailing EPS ₹46.04).
Q1 FY27 results (consolidated, filed 11 Aug 2026): revenue ₹8,017 crore (+22.0% year on year), net profit ₹990 crore (-34.9%); the price moved +1.2% on the first session after.
Q2 FY27 results are expected between 29 Oct 2026 and 12 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV

Macro sectorHealthcare

Basic industryPharmaceuticals

ISININE010B01027

SeriesEQ

Listed18 Apr 2000

History from27 Apr 2000

Sessions6,571

Turnover rank#150

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSE All Healthcare stocks on the NSE